Clinical trials in Eindhoven – page 4

169 clinical trials in Eindhoven, The Netherlands across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Eindhoven at a glance

169

clinical trials

Research sites3

Quick filters

169 trials in Eindhoven

Open in trial search

Ischaemic stroke

Recruiting

Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination

Registered drugNo placebo

Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Atorvastatin
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Hypothyroidism

Recruiting

Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

Registered drug

Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Uterine leiomyoma

Recruiting

Study Comparing Ulipristal Acetate and Surgery for Women with Symptomatic Uterine Fibroids

Registered drugNo placebo

Study Comparing Ulipristal Acetate and Surgery for Women with Symptomatic Uterine Fibroids

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Ulipristal Acetate
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Myocardial infarction

Recruiting

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Research Maatschap Cardiologen Rotterdam Zuid

Contact Research Centre

Cerebrovascular accident

Recruiting

Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

Registered drugNo placebo

Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Acetylsalicylic Acid
Sponsor:Stichting Radboud universitair medisch centrum

Contact Research Centre

Embolism venous

Recruiting

Study on Venous Thromboembolism Prevention with Enoxaparin Sodium and Drug Combination for Patients Undergoing Total Hip or Knee Replacement

Registered drugNo placebo

Study on Venous Thromboembolism Prevention with Enoxaparin Sodium and Drug Combination for Patients Undergoing Total Hip or Knee Replacement

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa
Sponsor:Leiden University Medical Center

Contact Research Centre

Atrial fibrillation+3

Recruiting

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Insel Gruppe AG

Contact Research Centre

Analgesic therapy

Recruiting

Study on Levobupivacaine, Paracetamol, and Diclofenac for Pain Relief After Esophageal Lesion Procedure in Patients with Precancerous Esophageal Lesions

Registered drugNo placebo

Study on Levobupivacaine, Paracetamol, and Diclofenac for Pain Relief After Esophageal Lesion Procedure in Patients with Precancerous Esophageal Lesions

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Diclofenac Sodium
Sponsor:Sint Antonius Ziekenhuis Stichting

Contact Research Centre

Rectal cancer

Recruiting

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Registered drugNo placebo

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Stichting Radboud universitair medisch centrum

Contact Research Centre

Colitis ulcerative+1

Recruiting

Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn's disease or ulcerative colitis

Registered drugNo placebo

Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn's disease or ulcerative colitis

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Adalimumab
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Rectal cancer

Recruiting

Evaluating SGM-101 (fluorochrome-labeled antibody) in patients with locally advanced or recurrent rectal cancer undergoing surgery

InvestigationalNo placebo

Evaluating SGM-101 (fluorochrome-labeled antibody) in patients with locally advanced or recurrent rectal cancer undergoing surgery

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Sponsor:Leiden University Medical Center

Contact Research Centre

Oesophageal adenocarcinoma

Recruiting

Study on Adding Trastuzumab and Pertuzumab to Treatment for Patients with Resectable HER2 Positive Esophageal Cancer

Registered drugNo placebo

Study on Adding Trastuzumab and Pertuzumab to Treatment for Patients with Resectable HER2 Positive Esophageal Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pertuzumab
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Eindhoven

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on advanced gastric cancer, acute myeloid leukemia, and melanoma. Studies include innovative imaging techniques and combination therapies targeting specific genetic mutations.

Gastric Cancer Treatment Studies
Novel Leukemia Therapies
Prostate Cancer Diagnostics

Research includes evaluation of PSMA-PET/CT scanning and personalized treatment approaches for various cancer types.

02 Neurological Disorders

Clinical investigations focusing on intracerebral hemorrhage, status epilepticus, and dementia. Studies aim to improve treatment outcomes for patients with various neurological conditions.

Post-Cardiac Arrest Care
Stroke Management
Dementia Behavior Treatment

Emphasis on developing targeted therapies and improving patient outcomes through personalized treatment approaches.

03 Endocrine and Metabolic Studies

Research targeting thyroid disorders and hormonal conditions. Studies evaluate new treatment approaches including radiofrequency ablation and hormone replacement therapies.

Thyroid Treatment Comparisons
Hormone Therapy Optimization
Metabolic Disease Management

Focus on comparing traditional and innovative treatment methods for better patient outcomes.

Back to the Netherlands All countries